Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

What’s Wrong with the PBM Market?

Posted on June 24, 2024 by John C. Goodman
  • In Oklahoma, CVS’s P.B.M., Caremark, charged the health plan for state employees $138,000 a year for a generic version of the cancer drug everolimus. Yet the same drugs was available from wholesalers for about $14.000.

  • In New Jersey, Cigna’s P.B.M., Express Scripts charged a 77-year-old retiree $211 for a three-month supply of his allergy drug, when the same drug was available at Costco for $22.

  • In California, CVS Caremark charged Blue Shield $3,000 a month for the cancer drug abiraterone acetate. For the same drug, Express Scripts charged Hyatt $1,500. It is available from wholesalers for $150.

Source: New York Times

This is a very good piece of investigative reporting. However, it missises the real story, which is explained in this piece at our website. People who need expensive drugs are being overcharged so that drug insurance premiums can be artificially lowered for everyone – including all the people who don’t need those drugs. In this way, the sick are subsidizing the healthy. Employers (and insurers generally) have a perverse incentive to attract the healthy and avoid the sick. They are not allowed to do that directly. So, they do it indirectly.

Join the conversation.Cancel reply

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 40 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom